Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin adjunctive therapy in children with partial onset seizures
2010-020852-79Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in Focal onset seizure (3 arms), sponsored by Pfizer. Primary endpoint: Log-transformed 28-day partial seizure rate. Started May 2011; status: completed.
02
Drugs
pregabalin
03
Conditions
Focal onset seizure
Beyond the preview
Go deeper on 2010-020852-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020852-79.